Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

被引:27
|
作者
Edwards, Morven S. [1 ]
Lane, Heidi J. [1 ]
Hillier, Sharon L. [2 ,3 ,4 ,5 ]
Rench, Marcia A. [1 ]
Baker, Carol J. [1 ,6 ]
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Univ Pittsburgh, Sch Med, Dept Obstet, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Gynecol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Sch Med, Dept Reprod Sci, Pittsburgh, PA USA
[5] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA
[6] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Group B Streptococcus; Vaccine; Antibody; Glycoconjugate; Polysaccharide; Durability; TOXOID CONJUGATE VACCINE; PREGNANT-WOMEN; DISEASE; ADULTS; IMMUNOGENICITY; INFECTION; SAFETY; LEVEL; IA;
D O I
10.1016/j.vaccine.2012.04.048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The duration of functional activity of group B streptococcal (CBS) glycoconjugate vaccine-induced capsular polysaccharide-specific (CPS) IgG was evaluated among healthy adult responders. Opsonophagocytic activity declined significantly from a 4-week post-immunization peak, but substantial functional activity, exceeding 1 log(10) reduction in CBS cfu/mL, was retained at 18 months to 2 years post-immunization for each CBS type assessed. The persistence of functional antibody activity when CBS CPS-specific IgG concentrations decline, although remaining significantly higher than pre-immunization levels, suggests that long-term protection may be expected from candidate CBS glycoconjugates administered to this population. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4123 / 4126
页数:4
相关论文
共 50 条
  • [1] Glycoconjugate vaccines to prevent group B streptococcal infections
    Paoletti, LC
    Kasper, DL
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (06) : 975 - 984
  • [2] Prevalence of antibodies against group B streptococcal capsular polysaccharides in healthy Chinese neonates
    Shen, XH
    Yang, YH
    Zhang, JH
    Berg, S
    Lagergard, T
    Trollfors, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (12) : 1179 - 1180
  • [3] Maternal group B streptococcal immunization: Capsular polysaccharide (CPS)-based vaccines and their implications on prevention
    Palmeiro, Jussara K.
    De Carvalho, Newton S.
    Botelho, Ana C. N.
    Fracalanzza, Sergio E. L.
    Madeira, Humberto M. F.
    Dalla-Costa, Libera M.
    VACCINE, 2011, 29 (21) : 3729 - 3730
  • [4] Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis
    Tissi, L
    von Hunolstein, C
    Bistoni, F
    Marangi, M
    Parisi, L
    Orefici, G
    JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (08) : 717 - 723
  • [5] Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice
    Paoletti, LC
    Pinel, J
    Rodewald, AK
    Kasper, DL
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05): : 1237 - 1239
  • [6] INDUCTION OF TYPE SPECIFIC, BIOLOGICALLY FUNCTIONAL ANTIBODIES TO CAPSULAR POLYSACCHARIDES AFTER IMMUNIZATION WITH MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE
    MCQUEEN, K
    PHIPPS, D
    QUATAERT, S
    EBY, R
    PILLAI, S
    PEDIATRIC RESEARCH, 1991, 29 (04) : A179 - A179
  • [7] Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns
    Suara, RO
    Adegbola, RA
    Mulholland, EK
    Greenwood, BM
    Baker, CJ
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1998, 90 (02) : 109 - 114
  • [8] Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan
    Matsubara, K
    Katayama, K
    Baba, K
    Nigami, H
    Harigaya, H
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (07) : 453 - 454
  • [9] Prevalence of Group B Streptococcal Type VI Capsular IgG Antibodies in Japan
    K. Matsubara
    K. Katayama
    K. Baba
    H. Nigami
    H. Harigaya
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 453 - 454
  • [10] Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation
    Pannaraj, Pia S.
    Edwards, Morven S.
    Ewing, Kristen T.
    Lewis, Amanda L.
    Rench, Marcia A.
    Baker, Carol J.
    VACCINE, 2009, 27 (33) : 4452 - 4456